This Article Full Text Full Text (PDF) All Versions of this Article: 200211-1302OCv1 168/5/594    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wallace, H. L. Articles by Southern, K. W. Search for Related Content PubMed PubMed Citation Articles by Wallace, H. L. Articles by Southern, K. W.

Nasal Airway Ion Transport and Lung Function in Young People with Cystic Fibrosis

Institute of Child Health, University of Liverpool, Liverpool, United Kingdom; and Division of Pediatric Pulmonology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Correspondence and requests for reprints should be addressed to Helen L. Wallace, M.D., Institute of Child Health, Alder Hey Children's Hospital, Eaton Road, Liverpool L12 2AP UK. E-mail: hwallace{at}liv.ac.uk

There is strong evidence that abnormal airway ion transport is the primary defect that initiates the pathophysiology of lung disease in cystic fibrosis (CF). To examine the relationship between airway ion transport abnormality and severity of lung disease, we measured nasal potential difference in 51 young people with CF using a validated modified technique. There was no correlation between any component of the ion transport measurement and clinical condition (respiratory function, chest radiograph score, or Shwachman clinical score). Thirty subjects, homozygous for the F508 mutation, were divided into those above and those below average respiratory function for their age. There was no significant difference in any of the ion transport parameters between those with above and below average pulmonary function. Of the 51 subjects, 10 had significant hyperpolarization after perfusion with a zero Cl^- solution (> 5 mV). This Cl^- secretory capacity did not correlate with above average lung function. These data do not support the assertion that the extent of lung disease in CF reflects the degree of ion transport abnormality. We suggest that although an ion transport abnormality initiates lung disease, other factors (e.g., environmental and genetic modifiers) are more influential in determining disease severity.

Key Words: nasal potential difference • FEV₁ • F508 • chloride secretion

This article has been cited by other articles:

				S. M. Rowe, F. Accurso, and J. P. Clancy Detection of Cystic Fibrosis Transmembrane Conductance Regulator Activity in Early-Phase Clinical Trials Proceedings of the ATS, August 1, 2007; 4(4): 387 - 398. [Abstract] [Full Text] [PDF]

				P G Noone and K W Southern Unravelling salt transport in cystic fibrosis Thorax, November 1, 2004; 59(11): 916 - 917. [Full Text] [PDF]

				I Fajac, D Hubert, D Guillemot, I Honore, T Bienvenu, F Volter, J Dall'Ava-Santucci, and D J Dusser Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients Thorax, November 1, 2004; 59(11): 971 - 976. [Abstract] [Full Text] [PDF]

				D. B. Salinas, N. Pedemonte, C. Muanprasat, W. F. Finkbeiner, D. W. Nielson, and A. S. Verkman CFTR involvement in nasal potential differences in mice and pigs studied using a thiazolidinone CFTR inhibitor Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L936 - L943. [Abstract] [Full Text] [PDF]

				K W Southernl and D Peckham Establishing a diagnosis of cystic fibrosis Chronic Respiratory Disease, October 1, 2004; 1(4): 205 - 210. [Abstract] [PDF]

				F. Mekus, B. Tummler, K. W. Southern, H. L. Wallace, and P. M. Barker Genes, Environment, Ion Transport, and Cystic Fibrosis Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 770 - 771. [Full Text] [PDF]

				M. J. Tobin Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2003 Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 277 - 287. [Full Text] [PDF]